Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx)GlobeNewsWire • 10/07/19
Pfizer shares up 1.3% premarket after reporting positive results in second trial of dermatitis treatmentMarket Watch • 09/27/19
Pharma Stocks Hammered As House Proposal Aims To Slash Drug PricesInvestors Business Daily • 09/10/19